Adebrelimab Plus S-1 for Resected Cholangiocarcinoma

Clinical trial NCT07561775 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07561775
Sponsor: Xingjun Guo
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma Biliary Tract Cancer

Start date: 2026-04-21
Primary completion: 2028-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.